This study evaluates the addition of continuous infusion of lidocaine or continuous infusion of magnesium sufate in the duration of spinal anesthesia.
Both lidocaine and magnesium sulfate have been shown to prolong spinal anesthesia. The number of studies using magnesium sulfate to improve spinal anesthesia is greater than the number of studies using lidocaine, and methodology varies significantly between studies. Adverse effects of lidocaine are different from magnesium sulfate's. Lidocaine has a wider therapeutic interval with fewer side effects, including: Drowsiness, Feeling Anxious, Feeling Cold, Nervous, Numbness And Tingling, Signs And Symptoms At Injection Site, Twitching. Magnesium sulfate's side effects include: heart disturbances, breathing difficulties, poor reflexes, confusion, weakness, flushing (warmth, redness, or tingly feeling), sweating, lowered blood pressure, feeling like you might pass out, anxiety, cold feeling, extreme drowsiness, muscle tightness or contraction, or headache.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
44
Magnesium Sulfate 15mg/kg/h
Lidocaine 1,5mg/kg/h
Hospital Universitário de Brasilia
Brasília, Federal District, Brazil
Sensitive block duration
Thermal and pinprick level lowering to S2
Time frame: 9 hours
Motor block duration
Time to Bromage return to baseline
Time frame: 9 hours
Two levels regression
Time from maximal thermal (cold) sensitive block level to lower two levels
Time frame: 9 hours
Pain at postanesthesia care unit
Maximum pain (0-10 verbal scale) during PACU
Time frame: 1-3 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.